CPRX Catalyst Pharmaceuticals, Inc. - Common Stock
$31,22
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 11, 2026
Zakres 52 tyg.
$19–$33
90% of range
Ocena Analityków
STRONG BUY
14 analysts
Cena Docelowa
$33
+7% upside
P/E (TTM)
13.9
ROE
—
Marża Zysku Netto
—
CPRX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$31.21
Kapitalizacja Rynkowa
—
P/E (TTM)
13.9
EPS (TTM)
$1.68
Przychody (TTM)
$589M
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$19 – $33
CPRX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$589M
2016-12-31
→
2025-12-31
EPS
$1.68
2018-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
2016-12-31
→
2024-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CPRX
Mediana porównawcza
P/E (TTM)
13.9
17.8
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CPRX
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CPRX
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CPRX
Mediana porównawcza
Revenue YoY (Przychody R/R)
19.8%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
40.1%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
37.7%
—
EPS YoY
28.2%
—
Net Income YoY (Zysk Netto R/R)
30.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CPRX
Mediana porównawcza
CPRX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 7 50,0%
- Kup 6 42,9%
- Trzymaj 1 7,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
5 analityków · 2026-05-20
Mediana
$32.00
Średnia
$33.30
← Poniżej wszystkich celów
$31.21
Niski
$31.50
Wysoki
$36.00
Średni cel
$32.00
+2,5%
Średnia cel
$33.30
+6,7%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.06%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $0.50 | $0.47 | 0.03% |
| 31 grudnia 2025 | $0.41 | $0.34 | 0.07% |
| 30 września 2025 | $0.42 | $0.34 | 0.08% |
| 30 czerwca 2025 | $0.41 | $0.39 | 0.02% |
| 31 marca 2025 | $0.45 | $0.35 | 0.10% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CPRX | — | 13.9 | 19.8% | — | — | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| ORKA | $1.48B | -3.3 | — | — | -25.9% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $589M | $492M | $398M | $214M | $141M | $119M | $102M | $500.0K | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $87M | $69M | $52M | $34M | $22M | $17M | $15M | · | · | · | · | · | |
| R&D Expense | $13M | $13M | $93M | $20M | $17M | $16M | $19M | $20M | $11M | $11M | $12M | $10M | |
| SG&A Expense | $194M | $178M | $134M | $57M | $50M | $44M | $37M | $16M | $7M | $8M | $9M | $4M | |
| Operating Expenses | $206M | $190M | $227M | $77M | · | · | · | $36M | $19M | $19M | $20M | $15M | |
| Operating Income | $258M | $195M | $87M | $102M | $52M | $41M | $32M | $-35M | $-19M | $-19M | $-20M | $-15M | |
| Other Non-op | $26M | $21M | $8M | $3M | $282.0K | $587.0K | $2M | $1M | $454.2K | $321.6K | $100.4K | $76.2K | |
| Pretax Income | $284M | $216M | $95M | $105M | $53M | $42M | $33M | $-34M | $-18M | $-18M | $-20M | $-16M | |
| Income Tax | $69M | $52M | $23M | $22M | $13M | $-33M | $2M | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $214M | $164M | $71M | $83M | $39M | $75M | $32M | $-34M | $-18M | $-18M | $-20M | $-16M | |
| EPS (Basic) | $1.75 | $1.38 | $0.67 | $0.80 | $0.38 | $0.72 | $0.31 | $-0.33 | · | · | · | · | |
| EPS (Diluted) | $1.68 | $1.31 | $0.63 | $0.75 | $0.37 | $0.71 | $0.30 | $-0.33 | · | · | · | · | |
| Shares (Basic) | 122,290,866 | 118,457,673 | 106,279,736 | 103,374,606 | 103,379,349 | 103,512,913 | 102,944,316 | 102,633,884 | · | · | · | · | |
| Shares (Diluted) | 127,257,929 | 124,943,603 | 113,753,154 | 111,375,631 | 107,795,585 | 106,242,273 | 106,020,936 | 102,633,884 | · | · | · | · | |
| EBITDA | · | $195M | $87M | · | · | · | · | $-35M | $-19M | $-19M | $-20M | $-15M |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $709M | $518M | $138M | $298M | $171M | $130M | $90M | $17M | $57M | $14M | $28M | $9M | |
| Short-term Investments | · | · | $0 | $0 | $20M | $10M | $5M | $37M | $27M | $27M | $26M | $26M | |
| Receivables | $126M | $65M | $54M | $10M | $7M | $6M | $11M | $0 | · | · | · | · | |
| Inventory | $37M | $20M | $16M | $7M | $8M | $5M | $2M | $56.0K | $0 | · | · | · | |
| Prepaid Expense | $21M | $21M | $13M | $5M | $4M | $8M | $4M | $2M | $1M | $1M | $2M | $5M | |
| Current Assets | $894M | $624M | $219M | $321M | $210M | $159M | $111M | $55M | $85M | $41M | $60M | $44M | |
| PP&E (Net) | $1M | $1M | $1M | $847.0K | $959.0K | $130.0K | $210.5K | $245.4K | $191.4K | $244.2K | $191.5K | $71.4K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $442.6K | $350.6K | $357.7K | $261.6K | $184.6K | |
| Accum. Depreciation | $1M | $1M | $723.0K | $406.0K | $275.0K | $340.0K | · | $197.1K | $159.2K | $113.5K | $70.1K | $113.2K | |
| Intangibles | $132M | $157M | $194M | $32M | $0 | · | · | · | · | · | · | · | |
| Total Assets | $1.10B | $851M | $470M | $376M | $238M | $192M | $112M | $60M | $85M | $42M | $60M | $44M | |
| Accounts Payable | $11M | $17M | $15M | $4M | $3M | $4M | $4M | $2M | $2M | $933.2K | $2M | $2M | |
| Accrued Liabilities | $136M | $104M | $61M | $54M | $24M | $18M | $20M | $7M | $2M | $1M | $2M | $4M | |
| Current Liabilities | $147M | $121M | $76M | $58M | $27M | $23M | $24M | $10M | $4M | $2M | $3M | $6M | |
| Capital Leases | $2M | $3M | $3M | $4M | $4M | $0 | $647.5K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $209.0K | $315.0K | $3M | $14M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $150M | $124M | $82M | $75M | $31M | $23M | $25M | $10M | $4M | $2M | $5M | $9M | |
| Common Stock | $123.0K | $121.0K | $107.0K | $105.0K | $103.0K | $104.0K | $103.4K | $102.7K | $102.5K | $83.0K | $82.9K | $69.1K | |
| Paid-in Capital | $480M | $442M | $266M | $250M | $233M | $223M | $216M | $211M | $207M | $147M | $145M | $105M | |
| Retained Earnings | $474M | $285M | $121M | $50M | $-26M | $-54M | $-129M | $-161M | $-127M | $-108M | $-90M | $-70M | |
| AOCI | $0 | $64.0K | $14.0K | $24.0K | $-148.0K | $31.0K | $9.5K | $-20.2K | · | · | · | · | |
| Stockholders' Equity | $954M | $728M | $388M | $300M | $207M | $170M | $88M | $51M | $81M | $39M | $55M | $35M | |
| Liabilities + Equity | $1.10B | $851M | $470M | $376M | $238M | $192M | $112M | $60M | $85M | $42M | $60M | $44M | |
| Shares Outstanding | 122,513,621 | 120,879,099 | 107,121,549 | 105,263,031 | 102,992,913 | 103,781,641 | 103,397,033 | 102,739,257 | 102,549,498 | 82,972,316 | 82,850,619 | 69,119,092 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $22M | $14M | $8M | $6M | $6M | $4M | $4M | $2M | $2M | $2M | $778.0K | |
| Deferred Tax | $-7M | $-9M | $-18M | · | $9M | $-33M | $0 | $0 | · | · | · | · | |
| Amort. of Intangibles | $37M | $37M | $33M | $1M | $0 | · | · | · | · | · | · | · | |
| Operating Cash Flow | $209M | $240M | $144M | $116M | $60M | $45M | $35M | $-26M | $-14M | $-18M | $-18M | $-13M | |
| CapEx | $58.0K | $556.0K | $231.0K | $29.0K | $1M | $11.0K | $19.0K | $92.0K | · | $96.1K | $23.5K | $57.3K | |
| Investing Cash Flow | $-58.0K | $-556.0K | $-294M | $9M | $-11M | $-5M | $37M | $-15M | $-4.0K | · | · | · | |
| Stock Issued | $0 | $141M | $0 | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $7M | $12M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $141M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-17M | $141M | $-11M | $2M | $-8M | $702.0K | $1M | $293.1K | $57M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-41M | $44M | $-14M | $19M | $7M | |
| Free Cash Flow | · | $239M | $143M | · | · | · | · | $-26M | · | $-18M | $-18M | $-13M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 39.7% | 21.8% | · | · | · | · | -7059.0% | · | · | · | · | |
| Net Margin | · | 33.3% | 17.9% | · | · | · | · | -6800.7% | · | · | · | · | |
| Pretax Margin | · | 44.0% | 23.7% | · | · | · | · | -6800.7% | · | · | · | · | |
| EBITDA Margin | · | 39.7% | 21.8% | · | · | · | · | -7059.0% | · | · | · | · | |
| ROA | · | 24.8% | 16.9% | · | · | · | · | -46.6% | -29.0% | -35.5% | -38.9% | -44.8% | |
| ROE | · | 23.6% | 19.4% | · | · | · | · | -59.2% | -30.6% | -38.1% | -44.6% | -54.8% | |
| ROIC | · | 20.3% | 16.9% | · | · | · | · | -69.5% | -23.1% | -49.0% | -36.8% | -41.4% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.2 | 2.9 | · | · | · | · | 5.8 | 20.0 | 19.8 | 17.4 | 7.5 | |
| Quick Ratio | · | 4.8 | 2.5 | · | · | · | · | 5.6 | 19.7 | 19.3 | 15.9 | 6.1 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.7 | 0.9 | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | 3.9 | 4.6 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | · | 8.3 | 12.5 | · | · | · | · | · | · | · | · | · |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.8% | 23.5% | 85.9% | 52.1% | 18.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 40.1% | 51.7% | 49.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 37.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.2% | 107.9% | -16.0% | 102.7% | -47.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 30.8% | 52.4% | -3.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 30.8% | 129.5% | -14.1% | 110.4% | -47.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 37.1% | 60.7% | -1.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 23.4% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $589M | $492M | $398M | $214M | $141M | $119M | $102M | $500.0K | $0 | $0 | $0 | $0 | |
| Net Income TTM | $214M | $164M | $71M | $83M | $39M | $75M | $32M | $-34M | $-18M | $-18M | $-20M | $-16M | |
| Market Cap | · | $2.52B | $1.80B | · | · | · | · | $197M | $401M | $87M | $203M | $205M | |
| P/E | 13.9 | 15.9 | 26.7 | 24.8 | 18.3 | 4.7 | 12.5 | -5.8 | · | · | · | · | |
| P/S | · | 5.1 | 4.5 | · | · | · | · | 394.5 | · | · | · | · | |
| P/B | · | 3.5 | 4.6 | · | · | · | · | 3.9 | 5.0 | 2.2 | 3.7 | 5.8 | |
| P / Tangible Book | 3.5 | 4.4 | 9.3 | 7.3 | 3.4 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | · | 10.5 | 12.5 | · | · | · | · | -7.7 | -29.2 | -4.8 | -11.3 | -15.9 | |
| P / FCF | · | 10.5 | 12.6 | · | · | · | · | -7.6 | · | -4.8 | -11.3 | -15.8 | |
| Earnings Yield | 7.2% | 6.3% | 3.8% | 4.0% | 5.5% | 21.3% | 8.0% | -17.2% | · | · | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $149M | $153M | $148M | $147M | $141M | $142M | $129M | $123M | $99M | $111M | $103M | $100M | $85M | $61M | $57M | $53M | |
| Cost of Revenue | $14M | $26M | $23M | $21M | $18M | $22M | $19M | $15M | $13M | $16M | $14M | $12M | $10M | $11M | $10M | $8M | |
| R&D Expense | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $84M | $4M | $4M | $4M | $8M | $4M | |
| SG&A Expense | $49M | $53M | $47M | $46M | $47M | $44M | $46M | $41M | $47M | $42M | $34M | $28M | $30M | $14M | $14M | $13M | |
| Operating Expenses | $52M | $55M | $50M | $50M | $51M | $48M | $49M | $44M | $50M | · | · | · | · | · | · | · | |
| Operating Income | $73M | $62M | $66M | $66M | $63M | $63M | $51M | $54M | $27M | $42M | $-37M | $47M | $36M | $31M | $25M | $29M | |
| Other Non-op | $11M | $10M | $5M | $3M | $8M | $11M | $6M | $2M | $2M | $5M | $-833.0K | $2M | $2M | $2M | $905.0K | $-324.0K | |
| Pretax Income | $84M | $72M | $71M | $69M | $71M | $74M | $57M | $56M | $29M | $47M | $-38M | $49M | $37M | $33M | $26M | $28M | |
| Income Tax | $20M | $19M | $18M | $17M | $15M | $18M | $13M | $15M | $6M | $12M | $-7M | $11M | $8M | $8M | $3M | $7M | |
| Net Income | $64M | $53M | $53M | $52M | $57M | $56M | $44M | $41M | $23M | $35M | $-31M | $38M | $30M | $25M | $23M | $22M | |
| EPS (Basic) | $0.52 | $0.42 | $0.43 | $0.43 | $0.47 | $0.46 | $0.37 | $0.35 | $0.20 | $0.32 | $-0.29 | $0.36 | $0.28 | $0.24 | $0.22 | $0.21 | |
| EPS (Diluted) | $0.50 | $0.40 | $0.42 | $0.41 | $0.45 | $0.44 | $0.35 | $0.33 | $0.19 | $0.33 | $-0.29 | $0.33 | $0.26 | $0.23 | $0.20 | $0.20 | |
| Shares (Basic) | 122,254,171 | -243,945,544 | 122,600,730 | 122,163,212 | 121,472,468 | -235,459,993 | 118,931,153 | 118,180,396 | 116,806,117 | -212,108,420 | 106,568,137 | 106,258,790 | 105,561,229 | -205,521,337 | 103,318,572 | 102,795,600 | |
| Shares (Diluted) | 126,903,391 | -254,333,531 | 127,090,194 | 127,543,284 | 126,957,982 | -248,523,301 | 125,407,279 | 124,655,999 | 123,403,626 | -220,474,646 | 106,568,137 | 113,673,534 | 113,986,129 | -218,916,220 | 111,986,025 | 109,264,730 | |
| EBITDA | $73M | · | $66M | $66M | $63M | · | $51M | $54M | $27M | · | $-37M | $47M | $36M | · | $25M | $29M |
Bilans 23
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $756M | $709M | $690M | $653M | $581M | $518M | $442M | $376M | $310M | · | $121M | $179M | $148M | · | $256M | $211M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | $10M | |
| Receivables | $131M | $126M | $106M | $66M | $71M | $65M | $58M | $57M | $60M | · | $48M | $43M | $33M | · | $9M | $10M | |
| Inventory | $35M | $37M | $28M | $19M | $20M | $20M | $20M | $18M | $20M | · | $9M | $11M | $10M | · | $7M | $8M | |
| Prepaid Expense | $19M | $21M | $28M | $21M | $14M | $21M | $18M | $24M | $14M | · | $14M | $9M | $7M | · | $4M | $4M | |
| Current Assets | $940M | $894M | $852M | $759M | $686M | $624M | $539M | $474M | $405M | · | $192M | $241M | $199M | · | $276M | $243M | |
| PP&E (Net) | $994.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $882.0K | $917.0K | |
| Accum. Depreciation | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $900.0K | $808.0K | · | $639.0K | $557.0K | $475.0K | · | $372.0K | $337.0K | |
| Intangibles | $122M | $132M | $129M | $138M | $147M | $157M | $166M | $175M | $185M | · | $167M | $176M | $184M | · | $33M | · | |
| Total Assets | $1.15B | $1.10B | $1.05B | $972M | $909M | $851M | $772M | $706M | $647M | · | $413M | $444M | $407M | · | $333M | $267M | |
| Accounts Payable | $7M | $11M | $9M | $6M | $11M | $17M | $12M | $7M | $10M | · | $5M | $4M | $3M | · | $3M | $2M | |
| Accrued Liabilities | $125M | $136M | $120M | $107M | $100M | $104M | $94M | $85M | $69M | · | $53M | $48M | $53M | · | $42M | $20M | |
| Current Liabilities | $132M | $147M | $129M | $113M | $112M | $121M | $105M | $92M | $80M | · | $58M | $53M | $57M | · | $45M | $22M | |
| Capital Leases | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $4M | $4M | |
| Other Non-current Liabilities | $280.0K | $209.0K | $161.0K | $309.0K | $259.0K | $315.0K | $3M | $2M | $3M | · | $4M | $13M | $13M | · | $15M | · | |
| Total Liabilities | $135M | $150M | $131M | $116M | $115M | $124M | $111M | $98M | $85M | · | $65M | $69M | $74M | · | $63M | $26M | |
| Common Stock | $122.0K | $123.0K | $123.0K | $122.0K | $122.0K | $121.0K | $119.0K | $119.0K | $118.0K | · | $107.0K | $107.0K | $106.0K | · | $104.0K | $103.0K | |
| Paid-in Capital | $489M | $480M | $473M | $462M | $452M | $442M | $432M | $423M | $417M | · | $262M | $258M | $254M | · | $246M | $239M | |
| Retained Earnings | $523M | $474M | $447M | $394M | $342M | $285M | $229M | $185M | $145M | · | $86M | $117M | $79M | · | $24M | $2M | |
| AOCI | $8.0K | $0 | $0 | $31.0K | $-17.0K | $64.0K | $0 | $0 | $0 | $14.0K | $15.0K | $19.0K | $11.0K | $24.0K | $32.0K | $-130.0K | |
| Stockholders' Equity | $1.01B | $954M | $920M | $856M | $794M | $728M | $661M | $609M | $561M | $388M | $349M | $375M | $334M | $300M | $270M | $241M | |
| Liabilities + Equity | $1.15B | $1.10B | $1.05B | $972M | $909M | $851M | $772M | $706M | $647M | · | $413M | $444M | $407M | · | $333M | $267M | |
| Shares Outstanding | 122,181,308 | 122,513,621 | 123,264,583 | 122,385,569 | 121,959,172 | 120,879,099 | 119,266,561 | 118,521,366 | 118,029,526 | · | 106,605,007 | 106,501,259 | 105,938,292 | · | 104,064,683 | 102,709,348 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $6M | $6M | $8M | $6M | $5M | $4M | $4M | $8M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Amort. of Intangibles | $10M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $7M | $580.0K | · | · | |
| Operating Cash Flow | $60M | $45M | $32M | $71M | $60M | $71M | $73M | $64M | $32M | $56M | $45M | $31M | $12M | $40M | $41M | $26M | |
| CapEx | $27.0K | $32.0K | $0 | $26.0K | $0 | $88.0K | $259.0K | $10.0K | $199.0K | $93.0K | $64.0K | $0 | $74.0K | $0 | $0 | · | |
| Investing Cash Flow | $-27.0K | $-32.0K | $0 | $-26.0K | $0 | $-88.0K | $-259.0K | $-10.0K | $-199.0K | $-38M | $-93M | $0 | $-162M | $0 | $-132.0K | · | |
| Stock Issued | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $141M | $0 | $0 | $0 | $0 | · | · | · | |
| Stock Repurchased | $15M | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $4M | |
| Net Stock Activity | $-15M | · | · | · | $0 | · | · | · | $141M | · | · | · | $0 | · | · | $-4M | |
| Financing Cash Flow | $-13M | $-26M | $5M | $872.0K | $3M | $4M | $-6M | $1M | $141M | $-665.0K | $-10M | $-214.0K | $149.0K | $2M | $4M | $-3M | |
| Free Cash Flow | $60M | · | · | · | $60M | · | · | · | $32M | · | · | · | $12M | · | · | · |
Rentowność 7
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 49.0% | · | 44.7% | 45.2% | 44.8% | · | 39.6% | 44.2% | 27.5% | · | -36.2% | 46.9% | 41.7% | · | 43.9% | 53.8% | |
| Net Margin | 42.7% | · | 35.6% | 35.5% | 40.1% | · | 34.1% | 33.2% | 23.6% | · | -30.0% | 37.9% | 34.6% | · | 39.7% | 40.7% | |
| Pretax Margin | 56.4% | · | 47.9% | 47.3% | 50.4% | · | 44.5% | 45.5% | 29.5% | · | -37.0% | 48.7% | 43.7% | · | 45.4% | 53.2% | |
| EBITDA Margin | 49.0% | · | 44.7% | 45.2% | 44.8% | · | 39.6% | 44.2% | 27.5% | · | -36.2% | 46.9% | 41.7% | · | 43.9% | 53.8% | |
| ROA | 6.2% | · | 5.8% | 6.2% | 7.3% | · | 7.4% | 7.1% | 4.4% | · | -8.2% | 10.6% | 9.0% | · | 8.2% | 9.1% | |
| ROE | 7.0% | · | 6.7% | 7.1% | 8.4% | · | 8.7% | 8.3% | 5.2% | · | -10.0% | 12.2% | 10.7% | · | 9.7% | 10.1% | |
| ROIC | 5.5% | · | 5.3% | 5.8% | 6.3% | · | 5.9% | 6.5% | 3.9% | · | -8.6% | 9.7% | 8.5% | · | 8.1% | 9.1% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.1 | · | 6.6 | 6.7 | 6.1 | · | 5.1 | 5.1 | 5.1 | · | 3.3 | 4.6 | 3.5 | · | 6.2 | 10.8 | |
| Quick Ratio | 6.7 | · | 6.2 | 6.4 | 5.8 | · | 4.7 | 4.7 | 4.7 | · | 2.9 | 4.2 | 3.2 | · | 5.9 | 10.2 |
Efektywność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.5 | · | 0.9 | 1.1 | 0.9 | · | 1.3 | 1.1 | 0.8 | · | 1.8 | 1.3 | 1.1 | · | 1.4 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.8 | 2.4 | 2.1 | · | 2.4 | 2.5 | 2.1 | · | 3.6 | 3.8 | 3.9 | · | 7.2 | 6.7 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $586M | · | $565M | $539M | $491M | · | $453M | $423M | $386M | · | $345M | $295M | $239M | · | $189M | $169M | |
| Net Income TTM | $225M | · | $206M | $194M | $165M | · | $77M | $71M | $60M | · | $59M | $112M | $87M | · | $68M | $57M | |
| Market Cap | $3.03B | · | $2.43B | $2.66B | $2.96B | · | $2.37B | $1.84B | $1.88B | · | $1.25B | $1.43B | $1.76B | · | $1.34B | $720M | |
| P/E | 13.9 | · | 12.1 | 14.1 | 18.4 | · | 34.3 | 27.7 | 32.5 | · | 23.4 | 13.6 | 21.3 | · | 20.7 | 13.2 | |
| P/S | 5.2 | · | 4.3 | 4.9 | 6.0 | · | 5.2 | 4.3 | 4.9 | · | 3.6 | 4.8 | 7.4 | · | 7.0 | 4.3 | |
| P/B | 3.0 | · | 2.6 | 3.1 | 3.7 | · | 3.6 | 3.0 | 3.4 | · | 3.6 | 3.8 | 5.3 | · | 4.9 | 3.0 | |
| P / Tangible Book | 3.4 | · | 3.1 | 3.7 | 4.6 | · | 4.8 | 4.2 | 5.0 | · | 6.9 | 7.2 | 11.7 | · | 5.6 | 3.0 | |
| P / Cash Flow | 50.8 | · | · | · | 49.3 | · | · | · | 58.9 | · | · | · | 145.5 | · | · | · | |
| P / FCF | 50.8 | · | · | · | 49.3 | · | · | · | 59.3 | · | · | · | 146.4 | · | · | · | |
| Earnings Yield | 7.2% | · | 8.3% | 7.1% | 5.4% | · | 2.9% | 3.6% | 3.1% | · | 4.3% | 7.4% | 4.7% | · | 4.8% | 7.6% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $589M | $492M | $398M | $214M | $141M |
| Marża Operacyjna % | — | 39.7% | 21.8% | — | — |
| Zysk netto | $214M | $164M | $71M | $83M | $39M |
| Rozwodniony EPS | $1.68 | $1.31 | $0.63 | $0.75 | $0.37 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | — | 5.2 | 2.9 | — | — |
| Wskaźnik Szybkości | — | 4.8 | 2.5 | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | $239M | $143M | — | — |
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.